MOLECULAR ANALYSIS OF LACI MUTANTS FROM BONE-MARROW OF B6C3F1 TRANSGENIC MICE FOLLOWING INHALATION EXPOSURE TO 1,3-BUTADIENE

被引:73
作者
SISK, SC [1 ]
PLUTA, LJ [1 ]
BOND, JA [1 ]
RECIO, L [1 ]
机构
[1] CHEM IND INST TOXICOL, RES TRIANGLE PK, NC 27709 USA
关键词
D O I
10.1093/carcin/15.3.471
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic exposure to 1,3-butadiene (BD) results in early occurrence and high incidence of lethal lymphomas in male B6C3F1 mice. Male B6C3F1 lacI transgenic mice (BigBlue(TM)) were exposed by inhalation to 0, 62.5, 625 or 1250 p.p.m. BD for 4 weeks (6 h/day, 5 days/week). The lacI(-) mutant frequency and mutational spectrum were evaluated in DNA isolated from bone marrow cells. Two weeks after exposure the lacI(-) mutant frequency in bone marrow from BD-exposed mice had increased 2- to 3.5-fold over air control mice. DNA sequence analysis of 56 and 54 lacI(-) mutants from the air control and butadiene-exposed groups, respectively, demonstrated that there was a shift in the spectrum of base substitution mutations at A:T sites in BD-exposed mice (6/26) compared to the air control mice (2/45). A:T-->T:A transversions were found only in BD-exposed animals. Sequence data also indicate that clonal expansion, a natural process in hematopoiesis, can contribute to the lacI(-) mutant frequency from bone marrow cells such that mutant frequency and mutation frequency are not equivalent. This study shows that BD is mutagenic in B6C3F1 transgenic mouse bone marrow, causing a shift in the mutation spectrum at A:T base pairs in BD-exposed mice compared to air control mice. Sequencing DNA from lacI(-) mutants from transgenic animals, to determine mutant/mutation frequency and mutational spectra after subchronic bioassay-like exposure conditions, will aid in linking exposure, dose and biological response for genetic risk assessment of BD.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 38 条
[1]  
ARCE GT, 1993, ENV HLTH PERSPECT, V86, P75
[2]  
BERNSTEIN A, 1990, CIBA F SYMP, V148, P158
[3]   SPECIES-DIFFERENCES IN THE DISPOSITION OF INHALED BUTADIENE [J].
BOND, JA ;
DAHL, AR ;
HENDERSON, RF ;
DUTCHER, JS ;
MAUDERLY, JL ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 84 (03) :617-627
[4]  
BONIVER J, 1981, CANCER RES, V41, P390
[5]   THE PROTO-ONCOGENE C-KIT ENCODING A TRANSMEMBRANE TYROSINE KINASE RECEPTOR MAPS TO THE MOUSE W-LOCUS [J].
CHABOT, B ;
STEPHENSON, DA ;
CHAPMAN, VM ;
BESMER, P ;
BERNSTEIN, A .
NATURE, 1988, 335 (6185) :88-89
[6]   THE REACTION OF 3,4-EPOXY-1-BUTENE WITH DEOXYGUANOSINE AND DNA INVITRO - SYNTHESIS AND CHARACTERIZATION OF THE MAIN ADDUCTS [J].
CITTI, L ;
GERVASI, PG ;
TURCHI, G ;
BELLUCCI, G ;
BIANCHINI, R .
CARCINOGENESIS, 1984, 5 (01) :47-52
[7]   CHEMICAL SUPPRESSION OF A SUBPOPULATION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS - 1,3-BUTADIENE PRODUCES A HEMATOPOIETIC DEFECT SIMILAR TO STEEL OR WHITE SPOTTED MUTATIONS IN MICE [J].
COLAGIOVANNI, DB ;
STILLMAN, WS ;
IRONS, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2803-2806
[8]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155
[9]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153
[10]  
CUNNINGHAM MJ, 1986, MUTAGENESIS, V1, P449